ADCs Built On Starpharma Delivery Tech To Be Tested By Merck
As it works to expand its antibody-drug conjugate (ADC) capabilities, Merck has strengthened its links...
After Roe, Bayer Engages Lobbyists For Contraception Access
While a large portion of the biopharma industry prepares for a battle over medication prices,...
Trodelvy Wins A Battle Against Breast Cancer With Gilead
Gilead staked money on Trodelvy providing a life-extension benefit when it failed to show promise...
Study Uncovers And Exploits Flaws In Some High-Risk Cancers
A team of researchers led by C. Patrick Reynolds, M.D., Ph.D., director of the Texas...
Nasal Administration Could Boost HIV And COVID-19 Vaccines
A team led by an assistant professor from the University of Minnesota in the US has...
Enhertu From AZ, Daiichi Sankyo Now Has The FDA Approval
With two significant FDA clearances in as many weeks, Enhertu from AstraZeneca and Daiichi Sankyo...
Pfizer Provides Evidence To Back The Clearance Of Prevnar 20
Although Pfizer beat Merck to sell its next-generation pneumococcal vaccination, it lost a more important...
As A Rapid Response, ViiV Creates A $500,000 Monkeypox Fund
In a press statement, ViiV Healthcare stated that the Monkeypox Emergency Response Fund would be...
Hanmi Brings Back Liver Drug After Raising Its Efficacy
After leveraging its microemulsion technology to increase the absorption rate and so address a shortcoming...
Almac Group Announces $65M Expansion of North American Headquarters in Pennsylvania
Almac Group, the global contract development and manufacturing organisation, today announces a $65 million, 100,000...
